JPS5379873A - 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug - Google Patents

22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug

Info

Publication number
JPS5379873A
JPS5379873A JP15248477A JP15248477A JPS5379873A JP S5379873 A JPS5379873 A JP S5379873A JP 15248477 A JP15248477 A JP 15248477A JP 15248477 A JP15248477 A JP 15248477A JP S5379873 A JPS5379873 A JP S5379873A
Authority
JP
Japan
Prior art keywords
22position
drug
derivative
substituted
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15248477A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6131100B2 (en, 2012
Inventor
Bozaato Furiidoritsuhi
Behingaa Eguberuto
Maiyaa Horusuto
Haize Arento
Katsuda Sutanisurafu
Sutetsuperu Kuruto
Towaato Robaatoson
Fuaataa Burufu
Shiyurosuman Kurausu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5379873A publication Critical patent/JPS5379873A/ja
Publication of JPS6131100B2 publication Critical patent/JPS6131100B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP15248477A 1976-12-22 1977-12-20 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug Granted JPS5379873A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762658183 DE2658183A1 (de) 1976-12-22 1976-12-22 In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
JPS5379873A true JPS5379873A (en) 1978-07-14
JPS6131100B2 JPS6131100B2 (en, 2012) 1986-07-17

Family

ID=5996272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15248477A Granted JPS5379873A (en) 1976-12-22 1977-12-20 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug

Country Status (16)

Country Link
US (1) US4188395A (en, 2012)
JP (1) JPS5379873A (en, 2012)
AT (1) AT361477B (en, 2012)
AU (1) AU516921B2 (en, 2012)
BE (1) BE862107A (en, 2012)
CA (1) CA1105934A (en, 2012)
CH (1) CH635323A5 (en, 2012)
DE (1) DE2658183A1 (en, 2012)
DK (1) DK571677A (en, 2012)
ES (1) ES465290A1 (en, 2012)
FI (1) FI773867A7 (en, 2012)
FR (1) FR2378763A1 (en, 2012)
GB (1) GB1560280A (en, 2012)
IL (1) IL53639A (en, 2012)
NL (1) NL7714074A (en, 2012)
SE (1) SE7714607L (en, 2012)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540678A (en) * 1978-09-08 1980-03-22 Fujisawa Pharmaceut Co Ltd Dihydropyridine derivative
JPS6157578A (ja) * 1984-08-17 1986-03-24 ジヨン・ワイス・アンド・ブラザー・リミテツド 複素環式化合物
JPS62145064A (ja) * 1985-12-13 1987-06-29 バイエル・アクチエンゲゼルシヤフト 新規なフツ素含有１，４−ジヒドロピリジン類
JPS63500379A (ja) * 1985-08-06 1988-02-12 ベ−リンガ−・マンハイム・イタリア・ソシエタ・ペル・アチオニ ２−チオメチル−置換−１，４−ジヒドロピリジン、それらの製造方法およびそれらを含有する医薬組成物
JPS6341460A (ja) * 1986-08-04 1988-02-22 アデイ−ル　エ　コンパニ− 新規なジヒドロピリジン誘導体

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
YU42386B (en) * 1981-03-13 1988-08-31 Krka Process for preparing 1,4-dihydro-pyridine derivatives
CS228917B2 (en) 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
JPS57175166A (en) 1981-04-23 1982-10-28 Banyu Pharmaceut Co Ltd Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
US4572908A (en) * 1982-12-21 1986-02-25 Pfizer Inc. Dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
FI852359L (fi) * 1984-06-27 1985-12-28 Hoffmann La Roche Dihydropyridinderivat.
GB8421039D0 (en) * 1984-08-17 1984-09-19 Wyeth John & Brother Ltd Heterocyclic compounds
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
CA1267416A (en) * 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8531625D0 (en) * 1985-12-23 1986-02-05 Shell Int Research Complex-forming polymers
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
US4983740A (en) * 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3974278A (en) * 1973-07-12 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540678A (en) * 1978-09-08 1980-03-22 Fujisawa Pharmaceut Co Ltd Dihydropyridine derivative
JPS6157578A (ja) * 1984-08-17 1986-03-24 ジヨン・ワイス・アンド・ブラザー・リミテツド 複素環式化合物
JPS63500379A (ja) * 1985-08-06 1988-02-12 ベ−リンガ−・マンハイム・イタリア・ソシエタ・ペル・アチオニ ２−チオメチル−置換−１，４−ジヒドロピリジン、それらの製造方法およびそれらを含有する医薬組成物
JPS62145064A (ja) * 1985-12-13 1987-06-29 バイエル・アクチエンゲゼルシヤフト 新規なフツ素含有１，４−ジヒドロピリジン類
JPS6341460A (ja) * 1986-08-04 1988-02-22 アデイ−ル　エ　コンパニ− 新規なジヒドロピリジン誘導体

Also Published As

Publication number Publication date
NL7714074A (nl) 1978-06-26
AT361477B (de) 1981-03-10
JPS6131100B2 (en, 2012) 1986-07-17
GB1560280A (en) 1980-02-06
CA1105934A (en) 1981-07-28
AU516921B2 (en) 1981-07-02
IL53639A0 (en) 1978-03-10
FR2378763A1 (fr) 1978-08-25
BE862107A (fr) 1978-06-21
FI773867A7 (fi) 1978-06-23
FR2378763B1 (en, 2012) 1980-09-19
IL53639A (en) 1981-11-30
AU3170877A (en) 1979-06-28
DK571677A (da) 1978-06-23
SE7714607L (sv) 1978-06-23
CH635323A5 (de) 1983-03-31
ATA912977A (de) 1980-08-15
US4188395A (en) 1980-02-12
DE2658183A1 (de) 1978-07-06
ES465290A1 (es) 1978-09-16

Similar Documents

Publication Publication Date Title
JPS5379873A (en) 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug
PT66735A (en) Cephalosporion derivatives and method for production thereof
HK8884A (en) New derivatives of perhydro-aza-heterocycles and processes for the production thereof
JPS52281A (en) 22*triazaspirodecanylakyl** benzisoquinolinedion derivatives and preparation method
JPS5287192A (en) 77aminothiazolylacetoamid cephalospolanate derivatives process for preparing same and pharmaceutical composition
JPS52122371A (en) *2h* pyrann22one derivative and method for their production and pharmaceutical composition containing same
JPS52133992A (en) Novel 1*44benzodioxane derivative and its production and pharmaceutical compound
JPS53105482A (en) 11**55*44hydroxyy2hh1*22benzothiazinee33yl** 1*2*44oxadiazolee33yl*methyl*ethanonees*ss dioxide compound and method for its production
JPS52153945A (en) New toropone derivative and process for manufacture thereof
IL52424A (en) 2,7-dihydroxy-5-isopropyliden-9-alkyl-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives and process for their preparation
JPS5363348A (en) Derivative of substituted oophenylenediamine * method of its production and its use as drug
JPS5365880A (en) Cydononeimineeacyl derivative and process for preparing same
IL52099A (en) 5,6-dihydroprostacyclin derivatives and process for their preparation
JPS51113898A (en) 88aminootheophiline derivative * production and application thereof
JPS5459271A (en) 22oxazolidone derivative and production thereof
JPS52125179A (en) Substituted piperazine derivative and method for its preparation and application thereof
IL52488A (en) 9-desacetyl daunoruiin derivatives and process for their preparation
JPS5289683A (en) Quinoxalineediinnoxide derivative * its production and antiimicrobial composition containing same
JPS53149984A (en) 5*66dihydroo22methyll1*44oxasine derivative* and method for its production
HK9184A (en) 3-phenoxypyridine derivative and its production
JPS5371074A (en) Substituted aminoethanol* method for its production and pharmaceutical use
JPS52122375A (en) Pyridoxine derivative and its production and medical composition thereof
JPS53127488A (en) Aminoaryll1*2*44triazine derivative*method for its production and arthritic drugs containing said derivative
JPS52122382A (en) Novel 3*44dihydrocarbostyril derivative and method for their production
JPS5373539A (en) Derivative of dinitrosulfanilamide and its use and method of production